RacquelDInnis-SheltonMD

Oncology • Birmingham, AL

Assistant Professor, Medicine, University of Alabama School of Medicine

Join to view full profile

Dr. Innis-Shelton is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Innis-Shelton's full profile

Already have an account?

Office
619 19th St S
Birmingham, AL 35249
Phone+1 205-934-4011

Fax+1 205-297-9411

Education & Training

University of Virginia Medical CenterFellowship, Hematology and Medical Oncology, 2006 - 2008
Wellstar Health System/Wellstar Cobb HospitalResidency, Internal Medicine, 1998 - 2001
Medical College of Georgia at Augusta UniversityClass of 1998

Certifications & Licensure

CA State Medical License 2001 - Present
AL State Medical License 2008 - 2024
VA State Medical License 2006 - 2008
GA State Medical License 2001 - 2001
American Board of Internal Medicine Hematology

Clinical Trials

Fludarabine / Total Body Irradiation Regimen for ALLO HCT in Acute Lymphoblastic Leukemia Start of enrollment: 2013 Aug 27
Completed
Phase 2
Post Transplant Cyclophosphamide (Cytoxan) for GvHD Prophylaxis Start of enrollment: 2013 Aug 27
Completed
Phase 2
Safety of Post-transplant Alpha-beta Depleted T-cell Infusion Following Haploidentical Stem Cell Transplant (Haplo SCT) Start of enrollment: 2014 Oct 09
Completed
Not Applicable
The Myeloma Pack: A Multi-Modality Educational Intervention Strategy to Engage Patients With Multiple Myeloma Start of enrollment: 2017 Nov 27
Active, not recruiting
Not Applicable
Join now to see all

Publications & Presentations

PubMed

23 citations
Detection of microsatellite instability-high (MSI-H) by liquid biopsy predicts robust and durable response to immunotherapy in patients with pancreatic cancer.
Sakti Chakrabarti, Leslie Bucheit, Jason Scott Starr, Racquel Innis-Shelton, Ardaman Shergill
Journal for Immunotherapy of Cancer. 2022-06-01
10 citations
Mobilization of Hematopoietic Progenitor Cells for Autologous Transplantation Using Pegfilgrastim and Plerixafor: Efficacy and Cost Implications
Nicole Watts, Marisa B. Marques, Daniel B. Peavey, Racquel Innis-Shelton, Ayman Saad
Biology of Blood and Marrow Transplantation. 2019-02-01
16 citations
Phase 1/2 Trial of Carfilzomib Plus High-Dose Melphalan Preparative Regimen for Salvage Autologous Hematopoietic Cell Transplantation Followed by Maintenance Carfilzom...
Luciano J. Costa, Heather Landau, Saurabh Chhabra, Parameswaran Hari, Racquel Innis-Shelton
Biology of Blood and Marrow Transplantation. 2018-07-01

Abstracts/Posters

A Phase II Clinical Trial of Post-Transplant Cyclophosphamide for Graft Versus Host Disease Prevention Following Myeloablative Peripheral Blood Stem Cell Matched Unrel...
Racquel Innis-Shelton, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Daratumumab, Carfilzomib, Lenalidomide and Dexamethasone (Dara-KRd) Induction, Autologous Transplantation and Post-Transplant, Response-Adapted, Measurable Residual Di...
Racquel Innis-Shelton, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019